The Institute For Cancer Research
Income Statement
Fiscal Year Start:
Jul 1
Revenues in 2024
$98,007,791
Program Services
49%
Other
40%
Contributions
8%
Investments
3%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Expenses in 2024
$97,174,266
Other
64%
Salaries & Benefits
18%
Offices, Occupancy & IT
7%
Fees to Service Providers
6%
Depreciation
4%
Grants
1%
Interest
<1%
Benefits to Members
0%
Advertising & Promotion
0%
Revenues
2023
2024
Change
Contributions
$12,658,553
$7,659,861
-39%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$42,234,562
$47,835,514
+13%
Membership Dues
$0
$0
-
Investments
$1,978,129
$2,881,291
+46%
Other
$41,911,044
$39,631,125
-5%
Total Revenues
$98,782,288
$98,007,791
-1%
Expenses
2023
2024
Change
Grants
$573,349
$1,113,868
+94%
Benefits to Members
$0
$0
-
Salaries & Benefits
$63,194,663
$17,131,487
-73%
Fees to Service Providers
$4,001,904
$5,805,951
+45%
Advertising & Promotion
$0
$0
-
Offices, Occupancy & IT
$7,655,165
$6,536,794
-15%
Interest
$619,914
$610,165
-2%
Depreciation
$3,354,429
$3,890,898
+16%
Other
$11,082,704
$62,085,103
+460%
Total Expenses
$90,482,128
$97,174,266
+7%
Net income
2023
2024
Change
Net income
+$8,300,160
+$833,525
-90%
Functional Expenses
Summary
2023
2024
Change
Program
$60,249,932
$65,403,673
+9%
Admin
$27,428,011
$28,705,781
+5%
Fundraising
$2,804,185
$3,064,812
+9%
Total Expenses
$90,482,128
$97,174,266
+7%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)